New Market Study: "Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2012"
Global Markets Direct's, 'Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections. Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, Half Year is built using data and information sourced...
View full press release